Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Defense was posted on April 30, 2007. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

A -- Visible InGaN Injection Lasers (VIGIL)

Closed
BAA07-28Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

N/A

Place of Performance

VA

Set-Aside

NONE

Documents

4

BAA 07-28 Visible InGaN Injection Lasers (VIGIL)

PDF, High priority: read this firstrfp
High

BAA 07-28 Visible InGaN Injection Lasers (VIGIL)

PDF, High priority: read this firstrfp
High

BAA 07-28 Visible InGaN Injection Lasers (VIGIL)

PDF, High priority: read this firstrfp
High

1_VIGILBAAEnclosure1%282%29.ppt

PPT

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

5 updates
PhaseClosed
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

Notice details unchanged. Attachments may have changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Advanced Research Projects Agcy
Contacts1 person available
OfficeARLINGTON, VA, 222032114, USA
Office AddressARLINGTON, VA, 222032114, USA
Contacts
Henryk D TemkinProgram Manager

Full Description

Show more
Broad Agency Announcement 07-28 - Visible InGaN Injection Lasers (VIGIL) FedBizOpps and Grants.gov Solicitation Notice Defense Advanced Research Projects Agency (DARPA), Contracts Management Office (CMO), 3701 North Fairfax Drive, Arlington, VA 22203-1714. A - Visible InGaN Injection Lasers (VIGIL), SOL BAA 07-28, DUE DATE: 060407, POC HENRYK TEMKIN, DARPA/MTO, FAX (703) 696-2206 PROGRAM OBJECTIVES AND DESCRIPTION The objective of the VIGIL program is to develop visible InGaN/GaN lasers. Specific minimum program goals include: - Laser emission wavelength of 500 nm - Room temperature CW output power of 1W - Wallplug efficiency of 30% - Demonstration of stable operation over a period of 1000 hr - Wafer yield on 2 diameter substrates of 20% The main technology development part of the VIGIL program will be conducted in three Phases, each having definite and measurable milestones, the most critical of which will be referred to as Go/No-Go (GNG) metrics. The length of each of these Phases and specific measurable milestones for each Phase will be proposed by bidders and will be factors considered as part of the source selection process (see below). In general, shorter Phases are preferable, but each Phase should clearly be adequate in duration to meet its objectives with reasonable risks and costs. Proposals should discuss plans for managing these factors. DARPA may consider focused proposals addressing specific technical challenges in epitaxy, (e.g. development of non-polar substrates or templates with low defect density), device design, (e.g. demonstration of active layer structures with high internal efficiency), or characterization, (e.g. methods of measuring interfacial electric fields of radiative recombination lifetime of minority carriers), that may be necessary to meet the above program goals. Those offering such proposals should provide unambiguous physical arguments, based on data or simulations, leading to estimates of their importance in achieving operational targets of the envisioned VIGIL laser. Such proposals should also specify the period of performance for each of their Phase(s) and identify measurable milestones by which performance could be monitored (see above). DARPA Broad Agency Announcement (BAA) No. 07-28, entitled Visible InGaN Injection Lasers (VIGIL) is provided as an attachment to this solicitation notice and includes information on the specific areas of interest; the submission process; abstract and proposal formats; evaluation and selection/funding processes; as well as all other pertinent administrative and contractual information. The BAA may be obtained from the FedBizOpps website: http://www.fedbizopps.gov/, Grants.gov website: http://www.grants.gov/, World Wide Web (WWW) at URL http://www.darpa.mil/mto (go to - solicitation area) or by fax, electronic mail, or mail request to the administrative contact address given below. Proposals not meeting the format or following the submission instructions described in the BAA may not be reviewed. PROPOSER'S QUESTIONS A Proposer's Questions, website will be posted for BAA 07-28 on the DARPA, Microsystems Technology Office solicitations page (www.darpa.mil/baa/#eto). If you would like to have a question answered and posted on this site, please send your question to the following address: BAA07-28@darpa.mil.

More opportunities from Department Of Defense → Defense Advanced Research Projects Agcy

Same awarding agency

NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

4 days ago

DEADLINE

in 26 days
View Details
NAICS: 541715
New
Federal
Intrinsic Market Resilience (IMR)
Solicitation # DARPA-PS-26-138
The Intrinsic Market Resilience (IMR) program, solicited by the DARPA Information Processing Techniques Office under DARPA-PS-26-138, is a 32-month initiative spanning Fiscal Years 2027 through 2029. The program aims to protect essential U.S. economic sectors from systemic risks and adversarial attacks targeting the public interfaces of modern electronic markets. By combining Large Language Model (LLM) automation with rigorous mathematical modeling, IMR seeks to develop tools that automatically translate informal regulatory and technical specifications into formal models to identify hidden weaknesses and recommend structural repairs. The work is divided into three technical areas: TA1 focuses on modeling and analysis, TA2 on resiliency and repair, and TA3 on establishing test and evaluation frameworks to validate the outputs of the first two areas. This procurement is conducted as an Other Transaction (OT) for Prototype Agreement under 10 U.S.C. 4022, with anticipated award ranges of 4.5 to 5 million dollars for TA1, 2.5 to 3 million dollars for TA2, and 5 to 6.5 million dollars for TA3. Eligible participants include small businesses, nonprofit research institutions, and nontraditional defense contractors. Proposers must adhere to strict security requirements, including CMMC Level 1 compliance at award and CMMC Level 2 status or a detailed compliance plan. All information must be handled according to NIST 800-171 and DFARS 252.204-7012 standards. Evaluation is based on technical approach, qualifications, technology transition viability, price, and security, with a particular emphasis on innovation and the feasibility of the proposed technical solution.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS